Tianjin Zhongrui Pharmaceutical

Tianjin Zhongrui Pharmaceutical is a China-based pharmaceutical company specializing in the development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 2003 and located in the Tianjin Binhai New Area, the company operates advanced production lines that meet international Good Manufacturing Practice (GMP) standards. Their core therapeutic focus includes cardiovascular diseases, anti-infectives, and respiratory conditions, with a product catalog featuring widely prescribed generics like amlodipine and azithromycin. As a key player in the regional biotech landscape, Tianjin Zhongrui provides both proprietary products and contract manufacturing services to a global clientele. The company is recognized for its integration of research and large-scale production capabilities.